| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |